Multi-Analyte Test System With Algorithmic Analysis For Detection Of Prostate Cancer
The Multi-Analyte Test System with Algorithmic Analysis for Detection of Prostate Cancer is an in vitro diagnostic test system that combines values from multiple assays, with or without additional patient information, to yield a score aiding in the detection of prostate cancer or guiding decisions regarding prostate biopsy. It requires PMA approval as an FDA Class 3 device, reflecting the high risk associated with cancer diagnostic decisions. There is no assigned regulation number, and it is reviewed under the Immunology panel. The device is not an implant and not life-sustaining.
Research product code QRF in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QRF
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- IM
- Submission Type
- 2
Device Characteristics
Definition
Test system that combines values from multiple assays with/without other patient information to yield a score value for aid in detection of prostate cancer and/or decision for prostate biopsy.
FEI Numbers
This FDA classification entry is associated with 3 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 3 registration numbers. Click on an entry to view related FDA registrations.